Keyword Analysis & Research: portal vein thrombosis treatment guidelines

uptodate.com

https://www.uptodate.com/contents/acute-portal-vein-thrombosis-in-adults-clinical-manifestations-diagnosis-and-management

WEBAug 29, 2022 · Overview of the treatment of proximal and distal lower extremity deep vein thrombosis (DVT) Pylephlebitis; Society guideline links: Hepatic, portal, and splenic vein thrombosis; Warfarin and other VKAs: Dosing and adverse effects

DA: 66 PA: 59 MOZ Rank: 88

nih.gov

https://www.ncbi.nlm.nih.gov/books/NBK534157/

WEBNov 23, 2022 · To reduce morbidity, prompt diagnosis and treatment are necessary. Patients treated with early anticoagulation have a 5 year survival of 85%. The acute condition has a much better prognosis than chronic portal vein thrombosis, where the liver function is often compromised.

DA: 41 PA: 54 MOZ Rank: 55

nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609842/

WEBJun 6, 2019 · In treatment and prevention of VTE and PE, the daily oral VKA dose targets to individualized therapeutic international normalized ratio value of 2.5 (range 2-3). 53. Direct-acting oral anticoagulants (DOACs): DOACs have been in increasing use for treatment of VTE, in a variety of clinical settings.

DA: 20 PA: 65 MOZ Rank: 69

nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252415/

WEBMar 7, 2021 · The Baveno VI consensus and the European Association for the Study of the Liver (EASL) clinical practice guideline recommend the followings: (a) duration of anticoagulation therapy should be more than 6 months; (b) anticoagulation therapy should be maintained for several months after complete portal vein recanalization or until liver ...

DA: 31 PA: 53 MOZ Rank: 22

nih.gov

https://pubmed.ncbi.nlm.nih.gov/33832217/

WEBIn this narrative review we will discuss the treatment of PVT in the three most common scenarios (cirrhosis-associated, cancer-associated and non-malignant non-cirrhotic PVT). We will also discuss the role of the DOACs and summarize recent guidelines on this topic.

DA: 55 PA: 19 MOZ Rank: 97

gastrojournal.org

https://www.gastrojournal.org/article/S0016-5085(21)03382-5/fulltext

WEBSep 24, 2021 · This guideline aims to provide recommendations for pertinent clinically relevant questions related to hemostasis of bleeding, as well as prevention and treatment of thrombosis in patients with cirrhosis.

DA: 99 PA: 49 MOZ Rank: 8

clevelandclinic.org

https://my.clevelandclinic.org/health/diseases/portal-vein-thrombosis

WEBOverview. Portal vein thrombosis is when a blood clot forms in the vein that carries blood to your liver. People who have cirrhosis of the liver face a higher risk of blood clots in their portal vein. What is portal vein thrombosis? Portal vein thrombosis (PVT) is the formation of a blood clot (thrombus) that narrows or blocks your portal vein. guidelines

guidelines

DA: 6 PA: 79 MOZ Rank: 69

rsna.org

https://pubs.rsna.org/do/10.1148/rg.230128.pres/full/

WEBPublished Online: October 5, 2023. The Baveno VII consensus provides recommendations for diagnosing and managing recent and chronic portal vein thrombosis and a standardized nomenclature to strengthen reporting in the absence and presence of cirrhosis. Download as PowerPoint » Read Full Article View All Presentations. Go To …

DA: 8 PA: 64 MOZ Rank: 81

journal-of-hepatology.eu

https://www.journal-of-hepatology.eu/article/S0168-8278(21)00265-8/fulltext

WEBPortal vein thrombosis. TIPS. Transplant. Introduction. Cirrhosis, particularly at the decompensated stage, is characterised by profound and complex haemostatic alterations that are both procoagulant and anticoagulant and could theoretically lead to both thrombotic and bleeding complications. [1]

DA: 58 PA: 45 MOZ Rank: 81

lww.com

https://journals.lww.com/ajg/fulltext/2020/01000/acg_clinical_guideline__disorders_of_the_hepatic.9.aspx

WEBAbstract. Disorders of the mesenteric, portal, and hepatic veins and mesenteric and hepatic arteries have important clinical consequences and may lead to acute liver failure, chronic liver disease, noncirrhotic portal hypertension, cirrhosis, and …

DA: 7 PA: 66 MOZ Rank: 11